Kardan-Yamchi, J.; Kazemian, H.; Battaglia, S.; Abtahi, H.; Rahimi Foroushani, A.; Hamzelou, G.; Cirillo, D.M.; Ghodousi, A.; Feizabadi, M.M.
Whole Genome Sequencing Results Associated with Minimum Inhibitory Concentrations of 14 Anti-Tuberculosis Drugs among Rifampicin-Resistant Isolates of Mycobacterium Tuberculosis from Iran. J. Clin. Med. 2020, 9, 465.
https://doi.org/10.3390/jcm9020465
AMA Style
Kardan-Yamchi J, Kazemian H, Battaglia S, Abtahi H, Rahimi Foroushani A, Hamzelou G, Cirillo DM, Ghodousi A, Feizabadi MM.
Whole Genome Sequencing Results Associated with Minimum Inhibitory Concentrations of 14 Anti-Tuberculosis Drugs among Rifampicin-Resistant Isolates of Mycobacterium Tuberculosis from Iran. Journal of Clinical Medicine. 2020; 9(2):465.
https://doi.org/10.3390/jcm9020465
Chicago/Turabian Style
Kardan-Yamchi, Jalil, Hossein Kazemian, Simone Battaglia, Hamidreza Abtahi, Abbas Rahimi Foroushani, Gholamreza Hamzelou, Daniela Maria Cirillo, Arash Ghodousi, and Mohammad Mehdi Feizabadi.
2020. "Whole Genome Sequencing Results Associated with Minimum Inhibitory Concentrations of 14 Anti-Tuberculosis Drugs among Rifampicin-Resistant Isolates of Mycobacterium Tuberculosis from Iran" Journal of Clinical Medicine 9, no. 2: 465.
https://doi.org/10.3390/jcm9020465
APA Style
Kardan-Yamchi, J., Kazemian, H., Battaglia, S., Abtahi, H., Rahimi Foroushani, A., Hamzelou, G., Cirillo, D. M., Ghodousi, A., & Feizabadi, M. M.
(2020). Whole Genome Sequencing Results Associated with Minimum Inhibitory Concentrations of 14 Anti-Tuberculosis Drugs among Rifampicin-Resistant Isolates of Mycobacterium Tuberculosis from Iran. Journal of Clinical Medicine, 9(2), 465.
https://doi.org/10.3390/jcm9020465